Antiviral agents
AssigneeQuantec Limited
InventorsRodney Wayne CLAYCOMB, Colin Roger OGLE, Katharine Helen ADAM
Life of this patent
Estimating the term…
Abstract
The present invention relates to products and processes for the treatment or prevention of viral infection(s). In particular the invention relates to the use of one or more proteins, typically obtained from milk, for the treatment or prevention of viral infection(s). In particular embodiments the invention uses combinations of milk proteins for the treatment or prevention of viral infection(s). The products of the invention may be used in combination with other active agents, including other antiviral agents.
Claims17
A method of preventing, inhibiting, or reducing the viral activity of a virus on or in a cell or on or in a subject, the method including the step of contacting the virus or the cell with an effective amount of a combination of at least two proteins, each protein having an isoelectric point of or above substantially 6.8 and which are extracted from milk.
(canceled)
A method of treating or preventing a viral infection in a subject, the method including the step of administering to the subject an effective amount of a combination of at least two proteins, each protein having an isoelectric point of or above substantially 6.8 and which are extracted from milk.
4-6. (canceled)
A combination of:
- (i) a combination of at least two proteins, each protein having an isoelectric point of or above substantially 6.8 and which are extracted from milk;
- and
- (ii) at least one antiviral agent.
A combination of at least two proteins, each protein having an isoelectric point of or above substantially 6.8 and which are extracted from milk, wherein where the combination includes lactoferrin the lactoferrin content of the combination is less than 40% w/w.
Dependencies are inferred from the claim text.